发明公开
- 专利标题: KETOREDUCTASE MUTANT
- 专利标题(中): KETOREDUKTASE突变
-
申请号: EP10851775申请日: 2010-05-21
-
公开(公告)号: EP2573174A4公开(公告)日: 2013-11-20
- 发明人: MAZUKA FUSUKE , FUKUSHIMA TAKAYOSHI , SUMIDA NAOMI , YANAI KOJI
- 申请人: MEIJI SEIKA PHARMA CO LTD
- 专利权人: MEIJI SEIKA PHARMA CO LTD
- 当前专利权人: MEIJI SEIKA PHARMA CO LTD
- 优先权: JP2010058631 2010-05-21
- 主分类号: C12N15/09
- IPC分类号: C12N15/09 ; C12N1/15 ; C12N1/19 ; C12N1/21 ; C12N5/10 ; C12N9/02 ; C12N15/00 ; C12P19/56 ; C12P21/02
摘要:
Disclosed are a ketoreductase mutant which can be used for an efficient production of daunorubicin derivatives, a DNA encoding the mutant, a transformant prepared by introducing the DNA thereinto to produce a daunorubicin derivative, and a process of producing a daunorubicin derivative using the transformant. The ketoreductase mutant has an amino acid sequence in which one amino acid residue or two or more amino acid residues selected from the group consisting of amino acids located at positions corresponding to the 42nd, 149th, 153rd, 270th, and 306th amino acids in the amino acid sequence of a ketoreductase (EvaE) from a chlororemomycin-producing bacterium (Amycolatopsis orientalis) are substituted with another amino acid residues.
信息查询
IPC分类: